Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
8.115 USD | -3.62% |
|
+13.71% | -27.80% |
06-27 | INmune Bio, Inc. Completes Blinded Interim Analysis of Phase II Alzheimer's Disease Trial | CI |
05-30 | Sector Update: Health Care Stocks Higher in Afternoon Trading | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-27.80% | 167M | |
+16.43% | 122B | |
+17.36% | 114B | |
+19.62% | 25.71B | |
-25.84% | 19.02B | |
-20.21% | 15.83B | |
-19.59% | 15.32B | |
-47.37% | 14.88B | |
+60.12% | 14.82B | |
+4.92% | 14.1B |
- Stock Market
- Equities
- INMB Stock
- News INmune Bio, Inc.
- Insider Sell: Inmune Bio